Mounjaro®
Starting from £179.99/mo
Start journey Learn moreFeeling persistently cold on Wegovy is a real and recognised experience, not a sign that something is going wrong. The most likely explanation is straightforward: as your body loses fat (which acts as insulation and generates heat) your baseline warmth drops. This is a physiological response to weight loss itself, not a drug side effect in the traditional sense. That said, a few other mechanisms are worth understanding, and in some cases a quick check with your GP is sensible. These are prescription-only medicines; a clinician reviews every patient before and during treatment, and any new or persistent symptom is worth raising with your prescriber.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The phrase patients use most often is that Wegovy has 'slowed everything down', as if the medicine is deliberately suppressing their body's warmth. That framing isn't quite right. Semaglutide works by activating GLP-1 receptors involved in appetite regulation and blood-sugar control, it reduces hunger signals and slows gastric emptying. It does not directly suppress thyroid function or switch off heat-generating pathways. What it does do, very effectively, is help people eat significantly less. And eating less changes how warm you feel.
Here's the mechanism: when calorie intake drops, your body lowers its basal metabolic rate as an energy-conservation response. Less fuel in means less heat produced. At the same time, fat tissue acts as both insulation and a metabolically active source of warmth. As that tissue decreases (which is the whole point of treatment) your natural insulation shrinks with it. The result is a body that runs a little cooler than it did before. This is documented across weight-loss interventions broadly, not specific to Wegovy. Semaglutide's mechanism of action is well understood, and cold sensitivity simply isn't listed among its direct pharmacological effects.
Understanding this distinction matters because it changes how you respond. If Wegovy were suppressing your thyroid, you'd need the drug reviewed. If your body is running cooler because it's burning less fuel and carrying less insulation, the appropriate response is usually patience, a layer of clothing, and good nutrition, specifically enough protein to preserve lean muscle, which is metabolically active and generates heat.
There are three overlapping reasons people on Wegovy feel cold, and they often arrive together. First, reduced calorie intake lowers your metabolic heat output. Second, declining fat mass reduces insulation. Third (and this one catches people off guard) significant nausea or appetite suppression can lead to lower-than-intended food intake, compounding the calorie deficit beyond what's planned.
The practical check worth doing takes under a minute: look at your recent meals and honestly estimate whether you've been eating enough protein. Muscle mass is your body's primary heat engine. Patients who are eating very little (sometimes because nausea has made food unappealing) can lose lean muscle alongside fat, which worsens cold sensitivity. If your meals have shrunk dramatically, that's the first thing to address with your prescriber or a dietitian. The relationship between food and semaglutide tolerance is nuanced, and getting it right matters for both comfort and outcomes.
The other thing worth ruling out is coincidental thyroid or iron changes. Hypothyroidism and iron-deficiency anaemia both cause cold intolerance, and both are common in adults who are also pursuing weight loss. If your cold sensitivity feels extreme, came on suddenly, or is accompanied by fatigue, hair changes or breathlessness, a blood test is the right next step, not stopping your medication.
For most people, yes, the sensation eases over time. As weight loss slows and stabilises, your metabolic rate finds a new equilibrium. Your body adapts to its new composition and the acute phase of calorie restriction passes. Many patients notice the cold feeling is most pronounced in the first few months of treatment, particularly after dose increases when appetite suppression is strongest, and our guide to feeling cold on Wegovy covers what to expect at each stage in more detail. You can read more about how to tell Wegovy is working if you're unsure whether what you're experiencing is part of normal treatment progression.
The NHS medicines guidance for semaglutide notes a GI-led side-effect profile (nausea, digestive changes) but cold intolerance is not listed as a direct adverse effect of the medicine. That's useful context. It means a cold feeling on its own, without other concerning symptoms, is unlikely to be a drug reaction requiring the medicine to be stopped. What it does mean is that your body is responding to weight loss, which is exactly what treatment is for.
If you're always cold on Wegovy and the feeling is significantly affecting your daily life, that's worth a conversation. Our prescribers are available for aftercare seven days a week. Questions about whether Wegovy is the right fit for your situation, or about whether treatment is achieving what it should, are exactly what clinical oversight exists to answer. It's also worth knowing how Wegovy is priced as part of ongoing treatment planning, clear cost information removes one layer of uncertainty.
Wegovy is a prescription-only medicine, and every repeat prescription at nume is clinically reviewed before it's issued. If you haven't started treatment yet and want to understand whether you're likely to be a suitable candidate, starting a free consultation is the natural first step.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.